The DEA hearing happened. The questions followed. And on July 21st, RLG brought four cannabis attorneys together to answer them and chat, live.
Cannabis rescheduling has been one of the most anticipated and most misunderstood developments in the history of the industry. When the DOJ issued its Attorney General Order and the DEA hearing was set for July 15th, operators, investors, and advisors across the country were left with more questions than answers. What does Schedule III actually mean? Does 280E go away? Do I need a DEA registration? What do I tell my investors?
These are not small questions, and the noise surrounding rescheduling has made it harder, not easier, to find clear answers.
In a webinar that lasted a little over 90 minutes, the panel delivered a complete breakdown of the rescheduling timeline, the significance of the DEA hearing, and the real-world implications for businesses operating in the space today.
In this webinar, our panel answers:
- Does Schedule III eliminate 280E-- and when?
- What did the DEA hearing actually decide?
- Do cannabis operators need a DEA registration?
- What does rescheduling mean for cannabis banking and investment?
- What should operators do right now while we wait for more clarity?
- Is rescheduling actually good for small cannabis businesses?
- What's still unresolved, and what's the timeline going forward?
- How do I talk to my investors and team about what changed?
- What are the compliance gaps nobody is talking about?
Watch the full recording below to get every question answered directly from the attorneys tracking this closest.
This video is age-restricted due to cannabis-related content. For the full recording, head to YouTube by visiting the link above.
To schedule a consultation to review your business and how Schedule III could affect it with an RLG attorney, you may do so here.
Make sure you're subscribed to our newsletter so you'll never miss a webinar recording.
.webp)
